121 related articles for article (PubMed ID: 11757703)
1. Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Wessendorf S; Lichter P; Schwänen C; Fritz B; Baudis M; Walenta K; Kloess M; Döhner H; Bentz M
Ann Hematol; 2001; 80 Suppl 3():B35-7. PubMed ID: 11757703
[No Abstract] [Full Text] [Related]
2. [Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Takagi T; Sakai C; Oguro M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):917-20. PubMed ID: 1605671
[No Abstract] [Full Text] [Related]
3. [Problems of cancer treatment in the elderly from the viewpoint of the chemotherapist--focusing on malignant lymphomas as a model of chemotherapy].
Oyama A; Suzuki H; Ogura M
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):858-61. PubMed ID: 2188607
[No Abstract] [Full Text] [Related]
4. [Malignant lymphoma and adult T-cell leukemia-lymphoma].
Kato K
Rinsho Ketsueki; 2014 Feb; 55(2):191-200. PubMed ID: 24598187
[No Abstract] [Full Text] [Related]
5. Dose density and dose intensity: where does CHOP go from here?
Portlock CS
Ann Oncol; 2002 Sep; 13(9):1329-30. PubMed ID: 12196356
[No Abstract] [Full Text] [Related]
6. [A comparative study of ABEP and ACOPE in the treatment of non-Hodgkin's lymphoma CS IV].
Yoshida T; Nakamura S; Ohtake S; Itoh K; Kobayashi K; Hirai J; Kanno M; Matsuda T; Naito K; Nakamura E
Rinsho Ketsueki; 1988 Sep; 29(9):1383-7. PubMed ID: 3216509
[No Abstract] [Full Text] [Related]
7. Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
Bartlett NL; Petroni GR; Parker BA; Wagner ND; Gockerman JP; Omura GA; Canellos GP; Robert M; Johnson JL; Peterson BA
Cancer; 2001 Jul; 92(2):207-17. PubMed ID: 11466671
[TBL] [Abstract][Full Text] [Related]
8. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
9. Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma.
Salles MT; Neyra O; Taja L; Cervantes G; Gagnière M; Cerrillo M; Mohar A; Osornio A; Reynoso E; Gorodezky G
Cancer Genet Cytogenet; 1992 Mar; 59(1):80-3. PubMed ID: 1372839
[TBL] [Abstract][Full Text] [Related]
10. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Longo DL; DeVita VT; Young RC
N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
[No Abstract] [Full Text] [Related]
11. Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
Czuczman MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-46-52. PubMed ID: 23570100
[No Abstract] [Full Text] [Related]
12. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
[No Abstract] [Full Text] [Related]
13. [Treatment of elderly patients with non-Hodgkin's lymphoma].
Titorenko IB; Kriachok IA
Lik Sprava; 2011; (5-6):79-85. PubMed ID: 22606896
[TBL] [Abstract][Full Text] [Related]
14. German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Gerhartz HH; Thiel E; Brittinger G; Dörken B; Engelhard M; Engert W; Enne W; Fuchs R; Hagen-Aukamp CH; Huhn D
Blut; 1988 Mar; 56(3):139-42. PubMed ID: 2451551
[No Abstract] [Full Text] [Related]
15. Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
Rübe C; Nguyen TP; Klöss M; Loeffler M; Trümper L; Pfreunschuh M
Ann Hematol; 2001; 80 Suppl 3():B84-5. PubMed ID: 11757716
[TBL] [Abstract][Full Text] [Related]
16. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
[No Abstract] [Full Text] [Related]
17. Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
Köppler H; Pflüger KH; Eschenbach I; Pfab R; Bruntsch U; Zeller W; Steinhauer EU; Gropp C; Oehl S; Lötzke E
Onkologie; 1990 Feb; 13(1):28-32. PubMed ID: 2186321
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Basaran G; Basaran M; Onat H
J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
[No Abstract] [Full Text] [Related]
19. [Application of CGH to the study of non-Hodgkin's lymphomas].
Arranz E; Benítez J
Sangre (Barc); 1999 Aug; 44(4):297-300. PubMed ID: 10589282
[No Abstract] [Full Text] [Related]
20. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
